DE60006587D1 - Makrozyclische liganden für metallpharmazeutika - Google Patents

Makrozyclische liganden für metallpharmazeutika

Info

Publication number
DE60006587D1
DE60006587D1 DE60006587T DE60006587T DE60006587D1 DE 60006587 D1 DE60006587 D1 DE 60006587D1 DE 60006587 T DE60006587 T DE 60006587T DE 60006587 T DE60006587 T DE 60006587T DE 60006587 D1 DE60006587 D1 DE 60006587D1
Authority
DE
Germany
Prior art keywords
metal
relates
pharmaceuticals
macrocyclic chelants
macrocyclic ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60006587T
Other languages
English (en)
Other versions
DE60006587T2 (de
Inventor
Shuang Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Application granted granted Critical
Publication of DE60006587D1 publication Critical patent/DE60006587D1/de
Publication of DE60006587T2 publication Critical patent/DE60006587T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6587Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having two phosphorus atoms as ring hetero atoms in the same ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE60006587T 1999-09-13 2000-09-07 Makrozyclische liganden für metallpharmazeutika Expired - Fee Related DE60006587T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15351299P 1999-09-13 1999-09-13
US153512P 1999-09-13
PCT/US2000/024482 WO2001019838A1 (en) 1999-09-13 2000-09-07 Macrocyclic chelants for metallopharmaceuticals

Publications (2)

Publication Number Publication Date
DE60006587D1 true DE60006587D1 (de) 2003-12-18
DE60006587T2 DE60006587T2 (de) 2004-09-16

Family

ID=22547523

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60024891T Expired - Fee Related DE60024891T2 (de) 1999-09-13 2000-09-07 Makrocyclische Chelatbildner für Metallopharmazeutika
DE60006587T Expired - Fee Related DE60006587T2 (de) 1999-09-13 2000-09-07 Makrozyclische liganden für metallpharmazeutika

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60024891T Expired - Fee Related DE60024891T2 (de) 1999-09-13 2000-09-07 Makrocyclische Chelatbildner für Metallopharmazeutika

Country Status (8)

Country Link
EP (1) EP1246830B1 (de)
JP (1) JP2003509434A (de)
AT (2) ATE254130T1 (de)
AU (1) AU7353400A (de)
CA (1) CA2382057A1 (de)
DE (2) DE60024891T2 (de)
ES (1) ES2211602T3 (de)
WO (1) WO2001019838A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20030174A1 (it) * 2003-07-31 2003-10-29 Univ Padova Coniugati polimerici per diagnostica e terapia
JP4559922B2 (ja) * 2005-06-21 2010-10-13 株式会社東芝 蛍光性錯体及びそれを用いた照明装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362476A (en) * 1984-10-18 1994-11-08 Board Of Regents, The University Of Texas System Alkyl phosphonate polyazamacrocyclic cheates for MRI
FR2612191B1 (fr) * 1987-03-13 1989-06-16 Centre Nat Rech Scient Macrocycles organiques phosphores, procede de fabrication et applications
US5462725A (en) * 1993-05-06 1995-10-31 The Dow Chemical Company 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
JPH10500401A (ja) * 1994-04-22 1998-01-13 モンサント カンパニー 金属錯体を用いる診断画像解析法
JP3573310B2 (ja) * 1996-02-20 2004-10-06 富士写真フイルム株式会社 平版印刷用不感脂化処理液

Also Published As

Publication number Publication date
CA2382057A1 (en) 2001-03-22
EP1246830B1 (de) 2003-11-12
AU7353400A (en) 2001-04-17
DE60024891T2 (de) 2006-08-24
ATE312837T1 (de) 2005-12-15
DE60006587T2 (de) 2004-09-16
DE60024891D1 (de) 2006-01-19
JP2003509434A (ja) 2003-03-11
ATE254130T1 (de) 2003-11-15
ES2211602T3 (es) 2004-07-16
EP1246830A1 (de) 2002-10-09
WO2001019838A1 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
Giblin et al. Design and characterization of α-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination
GR3026658T3 (en) Hydrazino-type radionuclide chelators having an n 3?s configuration
Moi et al. Stable bifunctional chelates of metals used in radiotherapy
ATE194845T1 (de) Von peptiden abgeleitete komplexbildner für radionuklide
ES2109495T3 (es) Tioureas sustituidas utilizadas como agentes quelantes bifuncionales.
DK0836485T3 (da) Kaskade-polymer-komplekser, fremgangsmåde til deres fremstilling og farmaceutiske midler indeholdende disse
NO301829B1 (no) 2-pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og farmasöytiske preparater basert på disse
NO991688D0 (no) Administrerbare sammensetninger og fremgangsmÕter til magnetisk resonansavbildning
DE69417426D1 (de) N2s2-chelatoren des hydrazino-typs
IS2059B (is) Lífefnafræðilega virkjuð skuggaefni til myndgreiningar
MX9709913A (es) Metaloconstrucciones determinadas estructuralmente y aplicaciones.
ATE58297T1 (de) Kupplungsmittel zum radiomarkieren von proteinen.
BR9707053B1 (pt) compostos contendo perfluoralquila e composiÇço farmacÊutica.
DE69941912D1 (de) Amphipatische Polycarboxylchelaten und Komplexen mit paramagnetischen Metallen als MRI kontrastmitteln
ATE296312T1 (de) Metalkomplexbildner
ATE294813T1 (de) Konjugate von gallensäure mit metallbindenden chelatverbdingungen und die verwendung davon
AU2002328981A1 (en) Peptides conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri)
Smith Human serum transferrin cobalt complex: stability and cellular uptake of cobalt
Francesconi et al. Preparation and characterization of [99TcO] apcitide: a technetium labeled peptide
BR9508435A (pt) Quelentes macrocíclicos seus quelatos e usos dos mesmos no campo diagnóstico
DE60006587D1 (de) Makrozyclische liganden für metallpharmazeutika
IL114858A0 (en) DTPA derivatives metal complexes thereof pharmaceutical and diagnostic agents containing the same and methods for the preparation thereof
Costopoulos et al. Structural Study by NMR of an Oxorhenium− RGD Decapeptide Complex for Application in Radiotherapy
Yurt Lambrecht et al. In vitro evaluation of 99mTc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines
DE69117741D1 (de) Neue vorangeordnete sechszähnige liganden verwendbar in röntgenologischen bildformenden wirkstoffen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee